PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Total Receivables: Rp840,449 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:DVLA PT Darya-Varia Laboratoria Tbk ISX:DVLA
73 GF Score
Price Rp1,560.00
GF Value Rp1,845.86
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Darya-Varia Laboratoria Tbk Total Receivables?

PT Darya-Varia Laboratoria Tbk ISX:DVLA 73 Total Receivables is Rp840,449 Mil as of Mar. 2026. GuruFocus rates ISX:DVLA with a GF Score™ of 73/100 and a GF Value™ of Rp1,845.86 (Modestly Undervalued). The stock has 4 warning signs investors should review.

PT Darya-Varia Laboratoria Tbk's Total Receivables for the quarter that ended in Mar. 2026 was Rp840,449 Mil.

PT Darya-Varia Laboratoria Tbk Total Receivables Related Terms

PT Darya-Varia Laboratoria Tbk Total Receivables Historical Data

* Premium members only.

The historical data trend for PT Darya-Varia Laboratoria Tbk's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Darya-Varia Laboratoria Tbk Total Receivables Chart

PT Darya-Varia Laboratoria Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 471,516.75 564,424.98 729,217.88 741,930.50 835,940.49

PT Darya-Varia Laboratoria Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 868,611.52 786,118.52 774,175.86 835,940.49 840,448.76
ISX:DVLA
73GF Score
PT Darya-Varia Laboratoria Tbk ISX:DVLA
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Darya-Varia Laboratoria Tbk Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of Rp840,449 Mil mean?
PT Darya-Varia Laboratoria Tbk (ISX:DVLA) has a Total Receivables of Rp840,449 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors.
Is PT Darya-Varia Laboratoria Tbk's Total Receivables too high?
PT Darya-Varia Laboratoria Tbk's current Total Receivables is Rp840,449 Mil. Overall, PT Darya-Varia Laboratoria Tbk has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Darya-Varia Laboratoria Tbk's Total Receivables compare to ZTS and UTHR?
PT Darya-Varia Laboratoria Tbk's Total Receivables of Rp840,449 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. PT Darya-Varia Laboratoria Tbk's current Total Receivables is Rp840,449 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Darya-Varia Laboratoria Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk (ISX:DVLA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp1,845.86, compared to a current price of Rp1,560.00 — trading 15.5% below its estimated fair value. The current Total Receivables is Rp840,449 Mil. PT Darya-Varia Laboratoria Tbk's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For PT Darya-Varia Laboratoria Tbk (ISX:DVLA), the current Total Receivables is Rp840,449 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk stock appears to be undervalued. The current stock price of Rp1,560.00 is trading 15.5% below its estimated GF Value™ of Rp1,845.86. GuruFocus considers PT Darya-Varia Laboratoria Tbk to be Modestly Undervalued.

Key valuation signals for ISX:DVLA:

  • Total Receivables: Rp840,449 Mil
  • GF Value™: Rp1,845.86 vs. price of Rp1,560.00 (15.5% below fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the ISX:DVLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Darya-Varia Laboratoria Tbk Business Description

Address Jalan. R.A. Kartini Kav. 8, 18th-19th Floor, South Quarter, Tower C, Jakarta, IDN, 12430
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, and equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics, wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory testing services, periodic inspection services, and many more activities. Its business segments include: prescription drugs; consumer health products, which derives key revenue; export and toll manufacturing services; and services.
73GF Score

Get the complete analysis for ISX:DVLA

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp1,560.00
Price
Rp1,845.86
GF Value